Anne Hertenstein
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Journal: Neuro-oncology
Published: October 11, 2017
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.
Journal: Oncotarget
Published: May 11, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Journal: Oncotarget
Published: May 09, 2016
Neurological sequelae of cancer immunotherapies and targeted therapies.
Journal: The Lancet. Oncology
Published: April 02, 2016
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Journal: Neuro-oncology
Published: March 30, 2016
Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma.
Journal: Journal of neuro-oncology
Published: March 28, 2016
Current status and future directions of anti-angiogenic therapy for gliomas.
Journal: Neuro-oncology
Published: May 14, 2015
Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression.
Journal: AJNR. American journal of neuroradiology
Published: March 25, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026